Notice - Prescription Drug List (PDL): Triamcinolone acetonide
The purpose of this Notice of Amendment is to announce the revised listing for Adrenocortical hormones to allow the nonprescription use of triamcinolone acetonide for the conditions listed below. Only the Human part of the PDL has been revised.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Notice - Prescription Drug List (PDL): Triamcinolone acetonideHTMLEnglish publication HTML
-
Notice - Prescription Drug List (PDL): Triamcinolone acetonideHTMLFrench publication HTML
Similar records